| NCTWX | RPMGX | NCTWX / RPMGX | |
| Total Expense Ratio | 0.59 | 0.77 | 77% |
| Annual Report Gross Expense Ratio | 0.59 | 0.77 | 77% |
| Fund Existence | 43 years | 34 years | - |
| Gain YTD | 3.721 | 0.062 | 6,031% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 2500 | 4,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 919M | 20.8B | 4% |
| Annual Yield % from dividends | 0.07 | 0.00 | - |
| Returns for 1 year | -9.95 | -5.63 | 177% |
| Returns for 3 years | 2.04 | -0.19 | -1,100% |
| Returns for 5 years | -17.18 | -24.20 | 71% |
| Returns for 10 years | 24.64 | 27.75 | 89% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GGOAX | 11.15 | 0.01 | +0.09% |
| Goldman Sachs Mid Cap Growth A | |||
| JOHAX | 29.76 | -0.01 | -0.03% |
| JOHCM International Select Investor | |||
| PRHSX | 94.44 | -0.31 | -0.33% |
| T. Rowe Price Health Sciences | |||
| THMEX | 16.85 | -0.07 | -0.41% |
| CCT Thematic Equity Institutional | |||
| BRSYX | 16.90 | -0.09 | -0.53% |
| MFS Blended Research Small Cap Eq R6 | |||